4 options
Modern methods of drug design and development / edited by Matthew Lloyd.
Holman Biotech Commons - Periodicals QP601 .M49 v.1 (1955)-v.148 (1987), v.150 (1987)-v.224 (1993), v.226 (1993)-v.228 (1993), v.230 (1994)-v.242 (1994), v.244 (1994)-v.253 (1995), v.257 (1996)-v.262 (1995), v.266 (1996)-v.284 (1997), v.286 (1997)-v.305 (1999), v.332 (2001)-v.333 (2001), v.341 (2001)-v.342 (2001) v.120 1986 (cum. index to v.81-94, 96-101) v.140 1988 (cum. index to v.102-119, 121-134) v.175 1990 (cum. index to v.135-139, 141-167) v.199 1993 (cum. index to v.168-174, 176-194) v.229 1995 (cum. index to v.195-198, 200-227) v.265 1996 (cum. index to v.228, 230-262) v.285 1998 (cum. index to v.263, 264, 266-289)
Available
Chemistry Library - Books QP601 .M49 v.1-v.193,v.195-v.207,v.209-v.220,v.222-v.228,v.230-v.259,v.261-v.263,v.265-v.285 v.286-v.365,v.367,v.369-v.654,v.656,v.658-v.720,v.722-v.725 v.168/174,176/194-v.195/198,200/227
Available
LIBRA QP601 .M49 v.690
Available from offsite location
LIBRA QP601 .M49 v.1-v.217, v.219-v.220, v.222-v.288, v.291, v.299, v.303 v.306 (2000)-v.321 (2000) v.323 (2000)-v.331 (2001), v.334 (2001)-v.340 (2001), v.343 (2002)-v.390 (2004) v.320 2000 (cum. index to v.290-319) v.355 2002 (cum. index to v.321-354)
Mixed Availability
- Format:
- Book
- Series:
- Methods in enzymology ; 0076-6879 v. 690.
- Methods in enzymology, 0076-6879 ; v. 690
- Language:
- English
- Subjects (All):
- Drug development--Methodology.
- Drug development.
- Drugs--Design--Methodology.
- Drugs.
- Physical Description:
- xxiv, 574 pages : illustrations (some color) ; 24 cm.
- Place of Publication:
- Cambridge, MA : Academic Press, an imprint of Elsevier, 2023.
- Contents:
- Recombinant protein purification for structural and kinetic studies: a case study using M. tuberculosis a-methylacyl-CoA racemase (MCR) / Otsile O. Mojanaga, K Ravi Acharya, and Matthew D. Lloyd
- Steady-state kinetic analysis of reversible enzyme inhibitors: a case study on calf alkaline phosphatase / Henry Brooke, Meghna Ghoshray, Archad Ibrahim, and Matthew D. Lloyd
- Non-equilibrium modalities of inhibition: characterizing irreversible inhibition for the ErbB receptor family members / Bharath Srinivasan
- Analysis of continuous enzyme kinetic data using ICEKAT / Karina L. Bursch, Michael D. Olp, and Brian C. Smith
- You get what you screen for: standards for experimental design and data fitting n drug discovery / Kenneth A. Johnson
- Analysis of enzyme reactions using NMR techniques: a case study with a-methylacyl-CoA racemase (AMACR) / Timothy J. Woodman and Matthew D. Lloyd
- Crystallographic fragment screening in academic cancer drug discovery / Mathew P. Martin, Jane A. Endicott, Martin E.M. Noble, and Natalie J. Tatum
- Fast fragment and compound screening pipeline at the Swiss Light Source / Dennis Peter Stegmann, Julia Steuber, Günter Fritz, Justyna Aleksandra Wojdyla, and May Elizabeth Sharpe
- Fragment-based screening by protein-detected NMR spectroscopy / Paul J. Kerber, Raymundo Nuñez, Davin R. Jensen, Angela L. Zhou, Francis C. Peterson, R. Blake Hill, Brian F. Volkman, and Brian C. Smith
- Methods for computer-assisted PROTAC design / Evianne Rovers and Matthieu Schapira
- High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation / Drake A. Russell and Matthew A. Cerny
- Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosis / Allan H. Pang, Keith D. Green, Oleg V. Tsodikov, and Sylvie Garneau-Tsodikova
- Design and evaluation of substrate-product analog inhibitors for racemases and epimerases utilizing a 1,1-proton transfer mechanism / Stephen L. Bearne
- Identification and biochemical characterization of small molecule inhibitors of ERK2 that target the D-recruitment site / R.M. Sammons, E.J. Cho, and K.N. Dalby
- Preparing recombinant "split AEP" for protein labeling / Muge Ma, Simon T.M. Tang, Matthew T. Dickerson, and Louis Y.P. Luk
- Mass cytometry as a tool in target validation and drug discovery / Edmund C.R. Watson, Warren Baker, David Ahern, Danson Loi, Adam P. Cribbs, and Udo Oppermann.
- Notes:
- Includes bibliographical references.
- Other Format:
- ebook version :
- ISBN:
- 0443158711
- 9780443158711
- OCLC:
- 1370925342
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.